ORIC Pharmaceuticals, Inc. (ORIC)

ORIC Pharmaceuticals Statistics

Total Valuation

ORIC has a market cap or net worth of $1.50 billion. The enterprise value is $1.22 billion.

Market Cap	1.50B
Enterprise Value	1.22B

Important Dates

The last earnings date was Monday, February 23, 2026, after market close.

Earnings Date	Feb 23, 2026
Ex-Dividend Date	n/a

Share Statistics

ORIC has 112.01 million shares outstanding. The number of shares has increased by 25.91% in one year.

Current Share Class	112.01M
Shares Outstanding	112.01M
Shares Change (YoY)	+25.91%
Shares Change (QoQ)	+3.67%
Owned by Insiders (%)	1.14%
Owned by Institutions (%)	78.77%
Float	64.60M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.44
P/TBV Ratio	3.91
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.13

Current Ratio	14.13
Quick Ratio	13.79
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -41.27% and return on invested capital (ROIC) is -28.07%.

Return on Equity (ROE)	-41.27%
Return on Assets (ROA)	-26.17%
Return on Invested Capital (ROIC)	-28.07%
Return on Capital Employed (ROCE)	-36.81%
Weighted Average Cost of Capital (WACC)	11.58%
Revenue Per Employee	n/a
Profits Per Employee	-$1.22M
Employee Count	106
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +74.74% in the last 52 weeks. The beta is 1.33, so ORIC's price volatility has been higher than the market average.

Beta (5Y)	1.33
52-Week Price Change	+74.74%
50-Day Moving Average	10.04
200-Day Moving Average	10.38
Relative Strength Index (RSI)	70.52
Average Volume (20 Days)	1,413,602

Short Selling Information

The latest short interest is 21.65 million, so 19.33% of the outstanding shares have been sold short.

Short Interest	21.65M
Short Previous Month	21.14M
Short % of Shares Out	19.33%
Short % of Float	33.51%
Short Ratio (days to cover)	12.10

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-143.00M
Pretax Income	-129.47M
Net Income	-129.47M
EBITDA	-141.78M
EBIT	-143.00M
Earnings Per Share (EPS)	-$1.47

Balance Sheet

The company has $281.49 million in cash and n/a in debt, with a net cash position of $281.49 million or $2.51 per share.

Cash & Cash Equivalents	281.49M
Total Debt	n/a
Net Cash	281.49M
Net Cash Per Share	$2.51
Equity (Book Value)	384.36M
Book Value Per Share	3.90
Working Capital	268.05M

Cash Flow

In the last 12 months, operating cash flow was -$110.97 million and capital expenditures -$712,000, giving a free cash flow of -$111.68 million.

Operating Cash Flow	-110.97M
Capital Expenditures	-712,000
Free Cash Flow	-111.68M
FCF Per Share	-$1.00

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ORIC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.91%
Shareholder Yield	-25.91%
Earnings Yield	-8.61%
FCF Yield	-7.43%

Analyst Forecast

The average price target for ORIC is $20.00, which is 49.03% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$20.00
Price Target Difference	49.03%
Analyst Consensus	Strong Buy
Analyst Count	13
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-28.78%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1